Showing results (111-120 of 640) with videos related to
Sort By:
Pageof 64
Cancer Research|January 20, 2004
Enhancement of DNA vaccine potency by coadministration of a tumor antigen gene and DNA encoding serine protease inhibitor-6Tae Woo Kim, Chien-Fu Hung, David A K Boyd, et al.Cell & Bioscience|June 30, 2011
In vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccinationChih-Ping Mao, Liangmei He, Ya-Chea Tsai, et al.Cancer Research|October 31, 2012
Dose-dense chemotherapy improves mechanisms of antitumor immune responseChih-Long Chang, Yun-Ting Hsu, Chao-Chih Wu, et al.Cancer Immunology, Immunotherapy : CII|September 27, 2012
Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccineShiwen Peng, Sofia Lyford-Pike, Belinda Akpeng, et al.Journal of Biomedical Science|January 29, 2024
FLT3L-induced virtual memory CD8 T cells engage the immune system against tumorsHsin-Fang Tu, Yu-Jui Kung, Ling Lim, et al.Journal of Virology|July 29, 2004
Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6Shiwen Peng, Hongxiu Ji, Cornelia Trimble, et al.Vaccine|August 19, 2003
Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringeCornelia Trimble, Cheng-Tao Lin, Chien-Fu Hung, et al.Human Gene Therapy|February 21, 2004
Vaccination with a DNA vaccine encoding herpes simplex virus type 1 VP22 linked to antigen generates long-term antigen-specific CD8-positive memory T cells and protective immunityTae Woo Kim, Chien-Fu Hung, Jeong Won Kim, et al.Cancer Research|July 3, 2021
Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7-Expressing Carcinoma in the Cervicovaginal TractTalia R Henkle, Brandon Lam, Yu Jui Kung, et al.Scientific Reports|July 3, 2026
A calreticulin-linked HPV-16 E7 minigene DNA vaccine elicits strong E7-specific CD8+ T-cell immunity and durable antitumor effects in a preclinical modelYu-Cheng Chang, Yichu Xu, Ya-Chea Tsai, et al.Pageof 64